Edelman: SGLT2 inhibitors (Farxiga, Invokana, Jardiance, Steglatro) and GLP1-RAs (Adlyxin, Byetta/Bydureon, Ozempic, Rybelsus, Trulicity, Victoza) have now become two of the most important classes of medications for type 2 diabetes
While Mounjaro activates the GLP-1 receptor, it is technically classified as a dual GIP/GLP-1 receptor agonist, not a pure GLP-1 medication
By targeting the brains reward and motivation circuits, it addresses the psychological drivers of overeating rather than just blocking nutrient absorption
Whether you are curious about starting a GLP-1 or looking to switch to a dual-agonist like tirzepatide, a personalized, medically supervised plan is the only safe way forward
Scenario C: Young, alreadylean exerciser chasing marginal gains Expect smaller probability of noticeable change
[2023-07-04] 7